VA-012
CAS No. 885898-58-8
VA-012( VA012 )
Catalog No. M16412 CAS No. 885898-58-8
VA-012 is a potent, selective 5-HT2C receptor positive allosteric modulator (PAM) that exhibits dose-dependent potentiation of 5-HT efficacy with EC50 of 16 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameVA-012
-
NoteResearch use only, not for human use.
-
Brief DescriptionVA-012 is a potent, selective 5-HT2C receptor positive allosteric modulator (PAM) that exhibits dose-dependent potentiation of 5-HT efficacy with EC50 of 16 nM.
-
DescriptionVA-012 is a potent, selective 5-HT2C receptor positive allosteric modulator (PAM) that exhibits dose-dependent potentiation of 5-HT efficacy with EC50 of 16 nM; shows no significant off-target activities, and low binding competition with serotonin or other orthosteric ligands; increases the anorectic effect combined with the SSRI sertraline; reduces food intake and body weight gain without causing CNS-related malaise.
-
In Vitro——
-
In Vivo——
-
SynonymsVA012
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
Recptor5-HT Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number885898-58-8
-
Formula Weight313.4
-
Molecular FormulaC21H19N3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC1=CC=C(C=C1)CN2C=C(C3=CC=CC=C32)CNC4=CN=CC=C4
-
Chemical Name1-(Phenylmethyl)-N-3-pyridinyl-1H-indole-3-methanamine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. García Cárceles J, et al. J Med Chem. 2017 Nov 8. doi: 10.1021/acs.jmedchem.7b00994.
molnova catalog
related products
-
Palonosetron hydroch...
Palonosetron (INN, trade name Aloxi) is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV).
-
SB 242084 hydrochlor...
SB 242084 is a potent, selective, brain penetrant 5-HT2C receptor antagonist.
-
Olanzapine
Olanzapine is an atypical antipsychotic, approved by the FDA in 1996.